fda statement on compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compound versions of GLP-1 drugs

Insulin secretory defect in familial partial lipodystrophy Type 2 and successful long-term treatment with a glucagon-like peptide 1 receptor agonist

Nearly two-fifths (37 per cent) of Canadian employers cover glucagon-like peptide-1 therapies for both diabetes and weight loss, up from 31 per cent in 2025 and just 17 per cent in 2024, according to a new survey by the International Foundation of Employee Benefit Plans

Nestl is not the only brand responding to consumer demand

To maximize their effectiveness: Maintain a balanced diet rich in antioxidants and essential nutrients

This golden spice is celebrated for its anti-inflammatory properties, helping to soothe and calm sensitive skin

O'Donovan, D